NanoUnit Method brings medicine to its destination in a patient’s body
We have created a successful solution to one of the big disadvantages
of immunotherapy and chemotherapy. These treatments typically distribute dangerous drugs throughout the whole patient’s body and mainly destroy healthy cells. Our method delivers medicines to their target destinations, making them much more efficient for all types of treatment.
The NanoUnit is not a drug or a medicine. As specialists in the field of medical and surgical devices, we developed the NanoUnit as a promising
method for future treatments. We invented the NanoUnit as a solution
for a gentle treatment of tumours and metastases through
the blood and lymphatic vessels.
A unique new solution to the big problems of cancer therapies
As specialists in the field new technologies, we are always thinking ahead to the future.
To create a new method that could solve the big problems
of chemotherapy and immunotherapy
We bring all existing medicines and drugs directly to their destinations
Developing and creating a medical device with proven efficacy in real treatment conditions
We proceeded with simulations and tests, such as preclinical studies,
to prove our concept could be successfully carried out
We created an individual nano-sponge and a MagniMed marker for
the succesful targeting of drugs
in the patient’s body
In finding the best sterile processes and packing solutions, we work according to the DIN EN ISO standards
Only the most excellent players can play
a major role in the rapidly expanding world. Our partners all have major strengths in the field of R&D. By joining forces, we created greater focus and the strength needed to be a top level player in the world of Nano and MedTech solutions and inventions.
R & D Team
Dr. med. Paul Herman (Surgeon)
Dr. med. K. Baloun (Surgeon)
Zdenek Pavelek (Engineering Expert)
Pavel Jonas (IT)
Thomas Baier (Validation Expert)
Dr. Franz Roskot (Physicist)
Arthur Leo Baier (Founder / Inventor)
Cooperation Partners / Investors
Luis Pasteur University Hospital Kosice
Institute of Inorganic Chemistry
Dr. Christoph Hochenegg (Investor)
Ing. Dietmar Hold (Co-Investor)
Team/Partner
Our Mission
We create and solve MedTech issues on behalf of our clinical clients. “Expansion of Innovations” is the key phrase that we realise through the introduction of unique and innovative solutions to medical technology. We are committed to continuous development through our participation in a variety of groundbreaking projects, as well as through the continuous improvement of human health. Our focus is everywhere where unresolved MedTech problems exist, and where we can support all the aims of oncology treatment.
Only the most excellent players can play a major role in the rapidly expanding world. Our partners all have major strengths in the field of R&D. By joining forces, we created greater focus and the strength needed to be a top level player in the world of solutions and inventions.
Our partner / Cooperations
Baier Medical Solutions
